Immunotropic properties of I→3; I→6-β-D-glucanes

Antibiotiki i Khimioterapiya

Volumn 45, Issue 2, 2000, Pages 37-44

  Besednova, N N ^a   Ivanushko, L A ^a   Zvyagintseva, T N ^a   Elyakova, L A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAN; IMMUNOLOGICAL ADJUVANT;

ANIMAL; B LYMPHOCYTE; DRUG EFFECT; DRUG SCREENING; IMMUNOLOGY; INNATE IMMUNITY; NEUTROPHIL; PHAGOCYTE; REVIEW; T LYMPHOCYTE; YEAST;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; B-LYMPHOCYTES; DRUG EVALUATION, PRECLINICAL; GLUCANS; IMMUNITY, NATURAL; NEUTROPHILS; PHAGOCYTES; T-LYMPHOCYTES; YEASTS;

EID: 0033631935     PISSN: 02352990     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. Kraus J., Franz O. In: Fungal cell walls and immune response. / Ed. J.P. Latge 1991. Berlin; Ser H53: 431-444.
2. Bohn J.A., BcMiller J.N. Carbohydr Polymers 1995; 28: 1: 3-14.
3. Kulicke W.M., Lettan A.J., Thielking H. Carbohydr Res 1997; 297: 2: 135-145.
4. Saito H., Yoshioka Y., Uchara N. et al. Carbohydr Res Ibid 1: 181-190.
5. Patchen M.L, D'Alesandro M.M., Brook J. et al. J Leukocyte Biol 1987; 42: 1: 95-105.
6. Kunimoto T., Baba H., Nitta K. J Biol. Response Modif 1986; 5: 3: 225-235.
7. Suga T., Maeda Y.Y., Ushida H. et al. Int J Immunopharmacol 1986; 8: 7: 691-699.
8. Patchen M.L., MacVitte T.J., Brook J. et al. 10th Intern Congr Reticuloendothelial Soc/ Japan, Sept 2-7. 1984. J Leukocyte Biol 1984; 36: 2: 228-229.
9. Reagents Immunology. Nature 1990; 346: 6284: 591.
10. DiLuzio N.R., Williams D.L., McNamee R.B. et al. J Nat Cancer Inst 1979; 24: 6: 773-779.
11. DiLuzio N.R. Springer Semin Immunopathol 1985; 8: 4: 387-400.
12. Abe S., Takahashi K., Tsubouchi J. et al. Gann 1984; 75: 5: 459-465.
13. Patchen M.L. Surv Immunol Res 1983; 2: 3: 237-242.
14. Chihara Y., Maeda Y.Y., Suga T. et al. Int J Immunother 1989; 5: 4: 145-154.
15. Murata T. et al. Cancer Res 1996; 87: 11: 1171-1178.
16. Chihara G. Tissue Culture and RES, Rehlinch, E. Basay, ed. New York; London 1984; 179-191.
17. Cawley S., Ormrod D.I., Miller T.E. Int J Immunother 1987; 3: 2: 159-170.
18. Okamura K., Suzuki M Chihara T. et al. Biotherapy 1989; 1: 1: 103-108.
19. Mantovani Y., Proto E. et al. Int J Oncology 1997; 10: 1: 213-221.
20. Moricawa K., Naguchi T., Yamazaki M., Mizuno D. Cancer Res 1986; 46: 1: 66-70.
21. Demleither S., Kraus J., Franz Y. Carbohydr Res 1992; 226: 2: 239-246.
22. Hadden I.W. Immunology Today 1993; 14: 6: 275-280.
23. DiLuzio N.R., Williams D.L. Infect Immun 1978; 20: 3: 804-810.
24. Reinolds I.A., Kastello M.D., Harrington D.C. et al. Infect Immun Ibid 1980; 30: 1: 51-57.
25. Cook I.A., Holbrook T.W., Parker B.W. J Reticuloendothelial Soc 1980; 27: 567-573.
26. Komatsu N., Nacume N., Suzuki M. et al. Int J Immunopharmacol 1980; 2: 3: 174
27. Janusz M.J., Austen K.F., Czop J.K. J Immunol 1987; 138: 1: 3897-3901.
28. Adachi Y., Ohno N., Oshava M. et al. Chem Pharm Bull 1990; 38: 4: 988-992.
29. Mizuhira U., Ono M., Yokofujita J. et al. Acta Histochem Cytochem 1983; 18: 2: 221-254.
30. Schultz R.M., Pepamathlakis I.D., Chirigos M.A. Immune modulation and control of neoplasia by adjuvant therapy. M.A. Chirigos ed. New York 1978; 241-248.
31. McCarty K., Musson R.A., Henson P.M. J Reticuloendothelial Soc 1982; 31: 131.
32. Czop J.K., Fearon D.T., Austen K.F. J Immunol 1978; 120: 1132-1141.
33. Kadish J.L, Choi C.C., Czop J.K. Fed Proc 1986; 45: 1115-1127.
34. Goldman R. Exp Cell Res 1988; 174: 2: 481-491.
35. Goldman R. Immunology 1988; 63: 2: 319-324.
36. Czop J.K., Austen K.F. Proc Natl Acad Sci 1985; 82: 9: 2751-2758.
37. Suzuki S., Hashimoto K., Oikawa S. et al. Chem Pharm Bull (Tokyo) 1989; 64: 37: 2: 410-413.
38. Chamuro J., Chihara Y. Immunol Ser 1984; 25: 409-436.
39. Sakagami Y., Mizoguchi Y., Shin T. et al. Biochem Biophys Res Commun 1988; 155: 2: 650-655.
40. Herberman R.B. Molecular Immunol 1982; 19: 10: 1313-1321.
41. Patchen M.L., MacVitte T.J., Brook J. Meth Findings Exper Clin Pharmacol 1986; 8: 3: 151-155.
42. Hashimoto K., Suzuki J., Osawa M. et al. J Pharmacobio Dyn 1990; 13: 8: 512-517.
43. Deimann W., Fahimi D. Lab Invest 1980; 42: 2: 217-224.
44. Patchen M.L., McVitte T.J. Macrophages and natural killer cells. Regulation and function. Proc 9th Intern RES Congr. Davos; New York; London 1982; 267-272.
45. Schlick E., Hartung K., Chirigos M.A. Cancer Immunol Immunother 1984; 18: 3: 226-232.
46. Peschle C., Marone Y., Venovese A. et al. Blood 1976; 47: 2: 325-337.
47. Williams D.L., Browder J.W., McName R. et al. Adv Exp Med Biol 1982; 155: 701-706.
48. Moricawa K., Naguchi T., Yamazaki M. et al. Cancer Res 1986; 46: 1: 66-70.
49. Morikava K., Takeda R., Yamazaki M. et al. Cancer Res Ibid 1985; 45: 4: 1496-1501.
50. Seljelid R., Bolgwald J., Hoffman J. et al. Immunopharmacol 1984; 7: 1: 69-73.